Northern Light Venture Capital

Northern Light Venture Capital is one of China’s longer-tenured top-tier venture firms, headquartered in Beijing with a thesis-driven approach across deep tech, enterprise software, and innovative healthcare. The firm has been investing across multiple cycles and is recognized as a serious institutional participant in the Chinese venture market, with healthcare exposure including biotech and health IT software at seed through Series B. The breadth across stages and sub-sectors reflects a multi-fund platform rather than a niche specialist, and the longevity gives the firm pattern recognition that few newer Chinese funds match. Limited public information about specific healthcare partner coverage in English-language sources is available, but Chinese-language coverage of the firm’s institutional standing is broad.

Check sizes range from 1 million to 5 million dollars across seed, Series A, and Series B, with the firm sized to take meaningful early positions and participate in follow-ons. Geography centers on China with Beijing as the base, and the firm’s networks extend across the major Chinese tech and healthcare hubs. Companies building purely outside the Chinese ecosystem will not align with the firm’s primary mandate.

For founders, the appeal is access to one of the more established names in Chinese venture and the institutional support that accompanies a multi-cycle fund platform. The trade-off, as with any top-tier firm, is that diligence is rigorous and competition for partner attention across portfolio companies is real. The right fit is ambitious China-market founders in deep tech, enterprise software, or healthcare with substantive technical or commercial differentiation. Initial conversations should clarify partner ownership of the deal, follow-on philosophy, and how the firm sequences support across the long arc from seed to growth.